|
|
|
Download StockRing Free Buy-Sell-Hold iPhone
App for 1,200 stocks in Energy Healthcare Finance Services & Tech
|
|
BUY DOW 30+: WSM WHR VFC SYT SPLS ENERGY: XCO TOT TLLP TESO RGP HEALTH: WX WST WOOF VPHM USPH
FINANCE: WLP SLF SIVB RLI OB SERVICES: WM WFM WCN WAG TV TECH: WDC SYMC STX SSNC SNPS
SELL DOW 30+: XEL WPZ WMT WLK VMC ENERGY: YZC WLL VNR VLO UNT HEALTH: VRX VAR UTMD TECH SYK
FINANCE: XLI WSH WDR WBK WAFD SERVICES: WYNN WMT VTR VNO VIP TECH: YNDX WCC VRSN VMW TXN
Our FREE iPhone App with Buy-Sell-Hold ratings for 1,200 stocks:
iPhone App Buy-Sell-Hold Ratings for 5-5-2013
|
|
|
5/24/2013 Friday, May 24, 2013 (Irvine, California) Today StockRing.com Recommendation is to "HOLD"for Optimer Pharmaceu (NASDAQ:OPTR) Stock.
OPTR stock opening price was $14.58 per share.
Current price of NASDAQ:OPTR Stock is $14.49 per share
and it is
$-0.18, (-1.23%) today
and it was trading in the daily range of $14.35 - 14.61 per share.
Current Bid Price for (NASDAQ:OPTR) stock is $14.50 and the Ask Price is $14.51. In the last 52 weeks
OPTR stock was trading in the range of $8.64 - 16.49. 50-Day Moving Average for (NASDAQ:OPTR) stock is
$13.33 and 200-Day Moving Average is $11.01. On average analysts predict that One Year Target Estimated price for
(NASDAQ:OPTR) stock is $17.43.
Optimer Pharmaceu (NASDAQ:OPTR) is rated as a wait on 5/23/2013 7:41:58 PM.
Optimer Pharmaceu (NASDAQ:OPTR) Market capitalization is $706.0M. (NASDAQ:OPTR) stock average daily volume is
819,574 shares per day.
However, on last trading session of 12:57pm, 2012
OPTR stock traded 114,595 shares.
Also The Number of days it would take short sellers on average to repurchase all the borrowed shares or Short Ratio for (NASDAQ:OPTR) stock is 9.80.
On previous trading session OPTR Stock closed at $14.67 per share.
Last year Optimer Pharmaceu (NASDAQ:OPTR) before taxes (EBITDA) (ttm) earned $-86.8M on total revenue of $106.6M.
Earnings Per Share - EPS (ttm) for OPTR stock is -1.2.
Thus, (NASDAQ:OPTR) Stock Price/Sales (ttm) ratio is 6.71 and Price/Book (mrq) ratio is 6.70.
(NASDAQ:OPTR) Stock does NOT PAY any dividend.
So at this time (NASDAQ:OPTR) Stock maintains Trailing Annual Dividend Rate at 0.00
.
|
StockRing Recommendations for Optimer Pharmaceu (NASDAQ:OPTR) Stock are updated daily here
http://StockRing.com/sr/Buy-Sell-Hold-Stock-Analysis-Ratings.asp?StockName=OPTR
At this time
StockRing recommends to buy LONG positions on many stocks from Dow 30+ stocks that currently have a
BUY or
SUPER BUY rating.
If you decide to take a SHORT position and actually sell some stocks sjort right now - please check the section of Dow 30+ stocks that have
a SELL or
SUPER SELL rating.
If you would like to receive Buy-Sell-Hold ratings for stocks from Energy, Healthcare, Finance, Services & Hi-Tech
sectors on your iPhone, then please
download Buy-Sell-Hold iPhone App here:
|
NASDAQ:OPTR Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max
Options More Info
|
5/24/2013
1 Year Stock market price chart for Optimer Pharmaceu (NASDAQ:OPTR) Stock on Friday, May 24, 2013
|
 | |
| 1 Year OPTR |
1 Year Dow Jones |
 |
 |
| 1 Year Nasdaq |
1 Year S&P 500 |
 |
 |
|
|
5/24/2013
5 days Stock market price chart for Optimer Pharmaceu (NASDAQ:OPTR) Stock on Friday, May 24, 2013
|
| |
| 5 Days OPTR |
5 Days Dow Jones |
 |
 |
| 5 Days Nasdaq |
5 Days S&P 500 |
 |
 |
|
|
|
|
|
EUROs for $1 DOLLAR: 30 days | |
| |
|
NASDAQ:OPTR Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max
Options More Info
|
| Last Trade: |
14.49 |
| Trade Time: |
12:57pm |
| Change: |
-0.18, (-1.23%) |
| Prev Close: |
14.67 |
| Open: |
14.58 |
| Bid: |
14.50 |
| Ask: |
14.51 |
| 1y Target Est: |
$17.43 |
| 50-Day Moving Average: |
13.33 |
200-Day Moving Average:
|
11.01 |
| Short Ratio: |
9.80 |
| Trailing Annual Dividend Rate: |
0.00
|
|
| Day's Range: |
14.35 - 14.61 |
| 52wk Range: |
8.64 - 16.49 |
| Volume: |
114,595 |
| Avg Vol: |
819,574 |
| Market Cap: |
706.0M |
| P/E (ttm): |
N/A |
| EPS (ttm): |
-1.2 |
| Div & Yield: |
0.00 (N/A%) |
| Revenue (ttm): |
106.6M |
| Earnings before Tax (EBITDA) (ttm): |
-86.8M |
| Price/Sales (ttm): |
6.71 |
| Price/Book (mrq): |
6.70 |
|
Should Cubist Pharmaceuticals, Inc. Bid For Optimer Pharmaceuticals?
iStockAnalyst (press release) - May 15, 2013
(By Mani) Cubist Pharmaceuticals, Inc. (NASDAQ: CBST), in addition to AstraZeneca and Astellas, had put in initial bids for Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR), according to a report on Bloomberg. Late February, Optimer commenced a process to ...
Affymax, Inc. (NASDAQ:AFFY), Santarus, Inc. (NASDAQ:SNTS), and Optimer ...
SBWire (press release) - May 10, 2013
Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) a biopharmaceutical company that engages in the development and commercialization of pharmaceutical products in the United States and Canada is currently down (-15.62%) on 3,415,124 shares traded after ...
Hot Stocks in Focus: DURECT Corporation, Affymax Inc, Optimer ... - Cogo
Hot Stocks: Affymax, Inc.(NASDAQ:AFFY), Santarus, Inc. (NASDAQ:SNTS ... - Openglobe
|
|
Falling Stocks on the Move (PTIE, DDD, DRRX, OPTR)SBWire (press release)Stockparlay.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets ...and more » |
|
Stock Downgrades: Dean Foods Cries Over Spilled MilkMinyanville.comOptimer Pharmaceuticals (OPTR): The stock is now Neutral from Outperform at Robert W. Baird. Pennant Investment (PNNT): Shares are now Perform from Outperform at FBR Capital. Rent-A-Center (RCII): RCII is reduced to Hold from Buy at Canaccord ...and more » |
|
|
| |
|
|
Copyright
© 2012 StockRing.com. All rights reserved.
Subscriber Agreement Privacy Agreement Stocks MutualFunds
Data and information is provided for informational purposes only, and is not intended
for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any
actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information
found therein.
|
| |
